Date |
Time |
Hall |
Session |
Role |
Title |
Name |
2018-10-19 |
13:10-13:25 |
Satellite Symposium |
Lunch and Satellite meeting for Boston Scientific Corporation——Conference Hall No.2-A(2F) |
Symposium |
The specificity of iliofemoral venous disease and the needs of the stent: 3 key factors of stent special for iliofemoral vein |
Zhenyu Shi |
2018-10-19 |
12:50-13:20 |
Satellite Symposium |
Lunch and Satellite meeting for Bayer company——Conference Hall No.5-A(1F) |
Symposium |
Clinical benefit for the VTE patients from long-term anti-coagulant treatment |
Zhenyu Shi |
2018-10-19 |
14:50-15:00 |
Conference Hall No.2-C(2F) |
Aortic Dissection(Simultaneous Interpretation ) |
Symposium |
Total endovascular treatment of Type B aortic dissection with aberrant right subclavian artery |
Zhenyu Shi |
2018-10-20 |
13:01-13:13 |
Satellite Symposium |
Lunch and Satellite Meeting for Acotec Scientific Co.Ltd——Conference Hall No.2-A(2F) |
Symposium |
Experience of using DCB in complex Femropopliteal lesions |
Zhenyu Shi |
2018-10-20 |
14:36-15:36 |
Conference Hall No.5-D(1F) |
IUA-Youngth committee-Venous Session |
Moderator |
|
Zhenyu Shi |
2018-10-20 |
15:54-16:30 |
Conference Hall No.5-B(1F) |
DCB Session------Acotec Scientific Co.Ltd |
Panel Discussion/Expert Comment |
讨论 |
Zhenyu Shi |